Allergies News and Research

Latest Allergies News and Research

A modified protein mediates development of lung fibrosis after cadmium/carbon black exposure

The triggers and causes of a severe scarring disease of the lungs -- idiopathic pulmonary fibrosis, or IPF -- remain unclear.

18 Mar 2021

Progesterone therapy may improve clinical outcomes for male COVID-19 patients

COVID-19 disproportionately affects men compared with women, raising the possibility that a hormone like progesterone may improve clinical outcomes for certain hospitalized men with the disease.

18 Mar 2021

Can vaccination and infection rates add up to reach Covid herd immunity?

It's been a long, dark winter of Covid concerns, stoked by high post-holiday case counts and the American death tally exceeding 530,000 lives lost.

17 Mar 2021

Testing for mRNA-1283, Moderna's next generation COVID-19 vaccine commences

As vaccine efforts against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease, roll out in various countries, Moderna ups the game by testing its next-generation COVID-19 vaccine.

16 Mar 2021

New Phase 1 study evaluates prime/boost HIV-1 vaccine formulated with combinations of adjuvants

A new Phase 1 vaccine study began today that will evaluate experimental prime/boost HIV-1 vaccine regimens formulated with combinations of different adjuvants, including one from the Army Liposome Formulation (ALF) family of adjuvants developed by scientists with the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research.

15 Mar 2021

Researchers discover new mechanism that contributes to airway hyperresponsiveness in asthma

In asthma, the airways become hyperresponsive. Researchers from Uppsala University have found a new mechanism that contributes to, and explains, airway hyperresponsiveness.

13 Mar 2021

U.S. Congress has clear opportunity to supercharge global health R&D, shows report

The U.S. Congress and Biden-Harris administration have a clear opportunity to supercharge global health research and development (R&D) in the wake of a pandemic that has revealed both the sector's chronic neglect and amazing potential.

12 Mar 2021

Scientists increase potency of HIV-1 antibody, identify new ways to develop vaccines

Much like coronavirus, circulating HIV-1 viruses mutate into diverse variants that pose challenges for scientists developing vaccines to protect people from HIV/AIDS.

12 Mar 2021

VEXAS syndrome in men is more common than previously thought

A rare disease first identified in 2020 is much more common than first thought, say researchers at the University of Leeds investigating its origins.

11 Mar 2021

NIAID awards $2.5 million in grants to support research on bacteriophage therapy

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded $2.5 million in grants to 12 institutes around the world to support research on bacteriophage therapy.

11 Mar 2021

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

To address the need for a high-quality neutralization assay against SARS-CoV-2, researchers from the NIAID modified and optimized a previously established fluorescence reduction neutralization assay (FRNA) to provide a quantitative assessment of a large number of infected cells through the use of a high-content imaging system.

11 Mar 2021

Study: Parents of children with food allergies experience worry, anxiety and stress

Parents of children with food allergies face significant worry, severe anxiety and post-traumatic stress – according to new research from the University of East Anglia.

11 Mar 2021

Study provides accurate data on allergic reactions related to mRNA COVID-19 vaccines

Almost immediately after the first mRNA-based COVID-19 vaccines were authorized for emergency use and were administered to individuals outside of clinical trials, reports of anaphylaxis--a life-threatening whole-body allergic reaction--raised widespread concerns among experts and the public.

10 Mar 2021

New study may lead to therapeutic strategies for chronic lung disease

Scientists at Washington University School of Medicine in St. Louis have implicated a type of immune cell in the development of chronic lung disease that sometimes is triggered following a respiratory viral infection.

10 Mar 2021

Human cerebral organoid model to screen drugs for treatment of Creutzfeldt-Jakob disease

Approximately two years after establishing a human cerebral organoid system to study Creutzfeldt-Jakob disease (CJD), National Institutes of Health researchers have further developed the model to screen drugs for potential CJD treatment.

9 Mar 2021

On vacci-dating: Singles seem enamored of sharing vaccination status online. Is that wise?

As cold weather descended upon Washington, D.C., last fall, I deleted my dating apps.

8 Mar 2021

Study: Monoclonal antibody 'cocktail' effective against all known COVID-19 variants

A monoclonal antibody "cocktail" developed at Vanderbilt University Medical Center (VUMC) to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published in the journal Nature Medicine.

5 Mar 2021

Multidrug-resistant S. aureus strains may be spreading between pigs, farmworkers in North Carolina

DNA sequencing of bacteria found in pigs and humans in rural eastern North Carolina, an area with concentrated industrial-scale pig-farming, suggests that multidrug-resistant Staphylococcus aureus strains are spreading between pigs, farmworkers, their families and community residents, and represents an emerging public health threat, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

5 Mar 2021

ACTIV-3 clinical trial evaluating investigational COVID-19 therapies closes enrollment in two sub-studies

The ACTIV-3 clinical trial, which is evaluating the safety and efficacy of investigational therapeutics for COVID-19 in hospitalized patients, has closed enrollment in two sub-studies: one examining the investigational monoclonal antibody therapy VIR-7831, and another evaluating the investigational combination monoclonal antibody therapy containing BRII-196 and BRII-198.

5 Mar 2021

Identification of neutralizing IFNL3 autoantibodies in severe COVID-19 cases

Scientists have recently developed a novel alternative molecular display technology called Molecular Indexing of Proteins by Self Assembly (MIPSA). Their research explains how this technology overcomes the critical disadvantages of PLATO and other full-length protein array technologies.

5 Mar 2021

Allergies News and Research

Latest Allergies News and Research

A modified protein mediates development of lung fibrosis after cadmium/carbon black exposure

Progesterone therapy may improve clinical outcomes for male COVID-19 patients

Can vaccination and infection rates add up to reach Covid herd immunity?

Testing for mRNA-1283, Moderna's next generation COVID-19 vaccine commences

New Phase 1 study evaluates prime/boost HIV-1 vaccine formulated with combinations of adjuvants

Researchers discover new mechanism that contributes to airway hyperresponsiveness in asthma

U.S. Congress has clear opportunity to supercharge global health R&D, shows report

Scientists increase potency of HIV-1 antibody, identify new ways to develop vaccines

VEXAS syndrome in men is more common than previously thought

NIAID awards $2.5 million in grants to support research on bacteriophage therapy

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

Study: Parents of children with food allergies experience worry, anxiety and stress

Study provides accurate data on allergic reactions related to mRNA COVID-19 vaccines

New study may lead to therapeutic strategies for chronic lung disease

Human cerebral organoid model to screen drugs for treatment of Creutzfeldt-Jakob disease

On vacci-dating: Singles seem enamored of sharing vaccination status online. Is that wise?

Study: Monoclonal antibody 'cocktail' effective against all known COVID-19 variants

Multidrug-resistant S. aureus strains may be spreading between pigs, farmworkers in North Carolina

ACTIV-3 clinical trial evaluating investigational COVID-19 therapies closes enrollment in two sub-studies

Identification of neutralizing IFNL3 autoantibodies in severe COVID-19 cases

Breath Analysis: How Could it Improve Healthcare and Diagnosis?

Advancing the Diagnosis and Treatment of Ovarian Cancer

World Health Day 2021 – “Building a fairer, healthier world”

Allergies News and Research

Latest Allergies News and Research

Newsletters you may be interested in